iih glp-1 Novel use of receptor agonist therapy for pediatric idiopathic intracranial hypertension: a case report GLP-1 Receptor Agonists in Idiopathic
Description
Diabetes Res Clin Pract 103:137149 Kraschnewski JL, Boan J, Esposito J et al (2010) Long-term weight loss maintenance in the United States
GLP-1 agonists may also have benefits for heart health, with research suggesting that they can reduce the risk of strokes, heart attacks, and death caused by cardiovascular disease by 20% compared to a placebo
FDA approval impact When Eli Lilly secures FDA approval, the commercial product will likely launch at $1,000 to $1,500 per month
All of these stimulate GLP-1 when eaten
Fierce Pharma article, 21 January 2023: [7] [8]
During maintenance therapy, many patients notice their elevated heart rate naturally decreases even while continuing the medication
